SmithKline Beecham plc v Alphapharm Pty Ltd [2001] FCA 271

SmithKline Beecham plc v Alphapharm Pty Ltd [2001] FCA 271

The documents Alphapharm offered to discover were sufficient for the applicants not to press further document discovery at this stage, but Prof Hibbert's evidence showed that Alphapharm lacked NMR, DSC and melting point data and that such analyses would be helpful to determine whether the raw material was similar to polymorphs described in the anhydrate patent. It was therefore appropriate to require provision of 50 grams of Alphapharm's raw material, subject to confidentiality restrictions limiting disclosure to legal advisers, patent attorneys, independent experts and one director of one applicant. Alphapharm was not released from its undertaking because it appeared to have been given...

Jurisdiction
Australia
Judgment Date
19 March 2001
Procedural Posture
Application for Preliminary Discovery and Provision of Samples Concerning Possible Patent Infringement / Reasons for Judgment on Application Under O 15 a of the Federal Court Rules
Outcome
Application granted in part: provision of raw material samples and confidentiality regime ordered in principle; further document discovery not pressed at this stage; release from undertaking declined; costs dealt with conditionally.
Legal Topics
['preliminary Discovery' 'pre Trial Discovery' 'confidential Information' 'trade Secrets' 'patent Infringement Inquiries' 'discovery of Documents' 'samples for Testing' 'undertakings']
['practice and Procedure' 'intellectual Property' 'patent Law'] ['preliminary Discovery' 'pre Trial Discovery' 'confidential Information' 'trade Secrets' 'patent Infringement Inquiries' 'discovery of Documents' 'samples for Testing' 'undertakings']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Application for Preliminary Discovery and Provision of Samples Concerning Possible Patent Infringement / Reasons for Judgment on Application Under O 15 a of the Federal Court Rules

Legal Issues

  1. 1 ["Whether the respondents' offer to provide documents was sufficient to enable the applicants to decide whether to commence patent infringement proceedings." 'Whether Alphapharm should be required to provide samples of raw material, tablets or excipients for testing under O 15A, r 12.' 'What confidentiality restrictions should apply to documents disclosed and test results obtained.' 'Whether the first respondent should be released from an undertaking not to sell, offer for sale, market, promote or export its product before the earlier of dismissal of the application or 1 August 2001.' 'What costs order should be made for the preliminary discovery application.']

Ratio Decidendi

The documents Alphapharm offered to discover were sufficient for the applicants not to press further document discovery at this stage, but Prof Hibbert's evidence showed that Alphapharm lacked NMR, DSC and melting point data and that such analyses would be helpful to determine whether the raw material was similar to polymorphs described in the anhydrate patent. It was therefore appropriate to require provision of 50 grams of Alphapharm's raw material, subject to confidentiality restrictions limiting disclosure to legal advisers, patent attorneys, independent experts and one director of one applicant. Alphapharm was not released from its undertaking because it appeared to have been given...

Court Disposition

Application granted in part: provision of raw material samples and confidentiality regime ordered in principle; further document discovery not pressed at this stage; release from undertaking declined; costs dealt with conditionally.

Orders

  • ['Alphapharm is to provide 50 grams of its raw material, paroxetine hydrochloride, to the applicants.' "Disclosure of information in discovered documents and results of tests on the sample is to be made only, subject to appropriate undertakings, to the applicants' solicitors, counsel, retained patent attorney,...